3.63
price down icon2.68%   -0.10
after-market Dopo l'orario di chiusura: 3.60 -0.03 -0.83%
loading

Sonnet Biotherapeutics Holdings Inc Azioni (SONN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
100.00%
-
1.00 - - -
Operating Expenses
9.87%
4.2294
3.8494 3.1734 3.5287 3.8686
Benefits Costs and Expenses
12.77%
3.4911
4.0023 -4.3273 3.5056 0.8217
Costs And Expenses
1.85%
4.0765
4.0023 3.1734 3.5287 3.8686
Operating Income/Loss
48.43%
-4.2294
-2.8494 -3.1734 -3.5287 -3.8686
Income/Loss From Continuing Operations Before Tax
16.28%
-3.4911
-3.0023 4.3273 -3.5056 0.3654
Income/Loss From Continuing Operations After Tax
10.45%
-3.4911
-3.1607 -3.1286 -3.5056 0.3654
Net Income/Loss
10.45%
-3.4911
-3.1607 -3.1286 -3.5056 0.3654
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
93.87%
3.9216
2.0228 -3.8266 5.0375 4.6177
Diluted Average Shares
93.87%
3.9216
2.0228 -3.8266 5.0375 4.8858
Basic Earnings Per Share
42.95%
-0.89
-1.56 -10.39 -0.70 0.08
Diluted Earnings Per Share
42.95%
-0.89
-1.56 -10.39 -0.70 0.07
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$37.01
price up icon 1.84%
$87.57
price up icon 0.30%
$33.17
price up icon 1.28%
$105.14
price up icon 0.06%
biotechnology ONC
$316.42
price down icon 0.50%
$165.76
price up icon 1.57%
Capitalizzazione:     |  Volume (24 ore):